The U.S. apoptosis assay market is projected to reach $6.18 billion and Europe $4.37 billion by 2035, supported by pharmaceutical R&D, precision medicine, cancer research, and advanced flow cytometry ...
According to MarketsandMarkets™, the Flow Cytometry Market is projected to reach USD 10.57 billion by 2034 from USD 5.56 billion in 2026, at a CAGR of 8.4% during the forecast period.
Apoptosis, or programmed cell death, is a tightly regulated biological process necessary for normal tissue maintenance and development. However, aberrations in apoptotic signaling networks are ...
According to MarketsandMarkets, the Flow Cytometry Market is projected to reach USD 10.57 billion by 2034 from USD 5.56 billion in 2026, at ...